Bicycle Therapeutics logo

Bicycle Therapeutics

BCYC | NASDAQ
Chart Builder DCF Calculator
$3.63
-$0.02 (-0.55%)
At close: Sep 21, 2026, 4:00 PM ET
$3.63
$0 (0.00%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$253.29M
Enterprise Value
$-244.47M
Beta
1.54
Average Volume
394.11K
Shares Outstanding (Diluted)
69.8M
Shares Change YoY
0.8%
Institutional Ownership
53.76%
Exchange
NASDAQ
ISIN
US0887861088

Price Performance

Price Change 1M
-16.2%
Price Change 3M
-9.3%
Price Change 6M
-22.4%
Price Change YTD
-45.7%
Price Change 1Y
-49.1%
Price Change 3Y
-81.9%
Price Change 5Y
-91.6%
1M CAGR (ann.)
-8.1%
1Y CAGR (ann.)
-47.3%
5Y CAGR (ann.)
-38.0%
All-Time CAGR
-15.0%

Valuation

PE Ratio
-1.33
Forward PE
N/A
PEG Ratio
-0.06
Forward PEG
0.30
PS Ratio
4.12
Forward PS
27.10
PB Ratio
0.49
P/FCF Ratio
-1.23
P/Adj. FCF Ratio
-1.26
P/OCF Ratio
-1.23
EV/Sales
-3.99
EV/EBIT
1.30
EV/EBITDA
1.33
EV/FCF
1.19
Earnings Yield
-75.2%
FCF Yield
-81.6%
Adj. FCF Yield
-79.3%

Financial Health

Net Cash
$510.05M
Total Debt
$13.68M
Cash & Short-Term Investments
$510.05M
Total Assets
$606.58M
Current Ratio
12.08
Quick Ratio
12.08
Debt / Equity Ratio
0.03
Debt / EBITDA
-0.07
Debt / FCF
-0.07
OCF / Debt
-15.04
Interest Coverage
-1,089.93
Altman Z-Score
-0.64
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
100.0%
Operating Profit Margin
-343.7%
EBITDA Margin
-299.3%
Net Profit Margin
-311.1%
FCF Margin
-335.9%
Adj. FCF Margin
-326.6%
SBC / Revenue
-9.3%
SBC Impact (per share)
-2.8%

Returns

Return on Assets
-31.4%
Return on Equity
-33.2%
Return on Invested Capital
-37.6%
Return on Capital Employed
-37.6%
Return on Tangible Assets
-31.4%

Historical Growth (CAGR)

Revenue CAGR 3Y
39.6%
Revenue CAGR 5Y
40.2%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
16.1%
EPS CAGR 5Y
5.1%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-10.5%
FCF CAGR 5Y
-33.5%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
21
EPS Growth Next 3Y
5.3%
Revenue Growth Next 3Y
-22.3%
Earnings Date
N/A
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$12
Price Target Upside
230.6%

Cash Flow

Operating Cash Flow
$-205.72M
Free Cash Flow
$-205.59M
Adj. Free Cash Flow
$-199.89M
FCF Per Share
-$2.95
OCF Per Share
-$2.95
OCF/S Ratio
-336.1%

Income Statement

Revenue
$61.21M
Gross Profit
$61.21M
Operating Income
$-210.36M
EBITDA
$-183.2M
Net Income
$-190.41M
EPS (Diluted)
-$2.73
Revenue / Employee
$212.52K
Profit / Employee
$-661.15K
Employees
288

© 2026 bestshares.com. All rights reserved.